Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Bauer

Showing results (11-20 of 339) with videos related to

Pageof 34
Sort By:
JAMA Internal Medicine|July 10, 2013
Vertebral augmentation vs nonsurgical therapy: improved symptoms, improved survival, or neither?Douglas C Bauer
JAMA|December 18, 2019
Bone Turnover Markers in Osteoporosis-ReplyDouglas C Bauer
Journal of General Internal Medicine|July 1, 2015
Screening Tests for Osteoporosis: Too Few for Some, Too Many for OthersDouglas C Bauer
The New England Journal of Medicine|October 18, 2013
Clinical practice. Calcium supplements and fracture preventionDouglas C Bauer
The Journal of Clinical Endocrinology and Metabolism|October 10, 2008
Randomized trial reporting in general endocrine journals: the good, the bad, and the uglyDouglas C Bauer
ACP Journal Club|November 4, 2006
Review: human parathyroid hormone reduces fractures and increases bone mineral density in severe osteoporosisDouglas C Bauer
The Journal of Clinical Endocrinology and Metabolism|December 7, 2010
Bisphosphonate use and atypical femoral fractures: getting down to brass tacksDouglas C Bauer
JAMA|July 12, 2019
Clinical Use of Bone Turnover MarkersDouglas C Bauer
Archives of Internal Medicine|June 27, 2012
Atypical femoral fracture risk in patients treated with bisphosphonatesDouglas C Bauer
The New England Journal of Medicine|January 24, 2014
Calcium supplements and fracture preventionDouglas C Bauer
Pageof 34

Showing results (11-20 of 339) with videos related to

Sort By:
Pageof 34
JAMA Internal Medicine|July 10, 2013
Vertebral augmentation vs nonsurgical therapy: improved symptoms, improved survival, or neither?Douglas C Bauer
JAMA|December 18, 2019
Bone Turnover Markers in Osteoporosis-ReplyDouglas C Bauer
Journal of General Internal Medicine|July 1, 2015
Screening Tests for Osteoporosis: Too Few for Some, Too Many for OthersDouglas C Bauer
The New England Journal of Medicine|October 18, 2013
Clinical practice. Calcium supplements and fracture preventionDouglas C Bauer
The Journal of Clinical Endocrinology and Metabolism|October 10, 2008
Randomized trial reporting in general endocrine journals: the good, the bad, and the uglyDouglas C Bauer
ACP Journal Club|November 4, 2006
Review: human parathyroid hormone reduces fractures and increases bone mineral density in severe osteoporosisDouglas C Bauer
The Journal of Clinical Endocrinology and Metabolism|December 7, 2010
Bisphosphonate use and atypical femoral fractures: getting down to brass tacksDouglas C Bauer
JAMA|July 12, 2019
Clinical Use of Bone Turnover MarkersDouglas C Bauer
Archives of Internal Medicine|June 27, 2012
Atypical femoral fracture risk in patients treated with bisphosphonatesDouglas C Bauer
The New England Journal of Medicine|January 24, 2014
Calcium supplements and fracture preventionDouglas C Bauer
Pageof 34